CDXS — CODEXIS, INC.

Nasdaq · Materials · Chemicals · CIK 1200375 ·
Last close
$2.60
Market Cap
$236.33M
52W High
$2.98
52W Low
$0.96
ADV30
1,166,666
Next earnings
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 15,248,000 13,184,000 -8,043,000 -8,704,000 129,370,000 36,571,000 86,136,000
Dec 2025 38,915,000 36,872,000 13,966,000 9,601,000 147,797,000 50,793,000 97,268,000
Sep 2025 8,601,000 6,136,000 -18,949,000 -19,615,000 123,961,000 25,351,000 85,417,000
Jun 2025 15,328,000 13,230,000 -12,862,000 -13,272,000 138,246,000 26,761,000 82,615,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-19,376,000
Investing CF
$23,502,000
Financing CF
$27,928,000
CapEx
$-4,471,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.52
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-606,780,000
Inventory
$1,817,000
Receivables
$10,686,000
ST Investments
$27,416,000
EBIT TTM
$-39,113,000
Pretax Income TTM
$-43,927,000
Interest Exp TTM
$4,814,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$78,092,000
EBITDA
$-20,550,000
Free Cash Flow
$-8,476,750
Enterprise Value
$244,094,080
Total Cash
$65,140,000
Total Debt
$72,903,000
Shares Out
90,896,567
Trailing EPS
$-0.35
Book Value
$0.48
ROE
-68.9%
ROA
-12.5%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 70,387,000 -38,332,000 -43,974,000 147,797,000 97,268,000 -19,376,000
Dec 2024 59,345,000 -58,354,000 -65,276,000 149,011,000 82,084,000 -49,410,000
Dec 2023 70,143,000 -54,801,000 -76,240,000 136,561,000 49,946,000 -52,638,000
Dec 2022 138,590,000 -31,714,000 -33,592,000 250,393,000 105,596,000 11,284,000
Dec 2021

TTM Snapshot

Revenues TTM
$93,349,000
NetIncome TTM
$-63,296,000
OpCashFlow TTM
$0
Assets (Latest)
$149,011,000
Forward EPS
$-0.37

Peers — same industry

TickerNameMarket CapLastDaily %
MDWD MediWound Ltd. $214.38M $16.68
PTNM Pitanium Ltd $207.93M $10.39
ACB AURORA CANNABIS INC $204.58M $3.46
LODE Comstock Inc. $304.41M $4.01
NAGE Niagen Bioscience, Inc. $307.43M $3.86

News headlines (Yahoo Finance, 1h cache)

Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
2026-05-20 13:00 · Yahoo
Spotlight On Promising Penny Stocks For May 2026
2026-05-11 18:05 · Yahoo
Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58
2026-05-11 11:47 · Yahoo
Codexis (CDXS) Q1 2026 Earnings Transcript
2026-05-08 19:32 · Yahoo
Codexis, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 23:05 · Yahoo
Codexis Q1 Earnings Call Highlights
2026-05-07 21:39 · Yahoo
Codexis Reports First Quarter 2026 Financial Results
2026-05-07 20:05 · Yahoo
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
2026-05-05 11:25 · Yahoo
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
2026-04-30 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.